Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1981-07-23
1985-09-10
Rose, Shep K.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
424 89, A61K 39245
Patent
active
045406693
ABSTRACT:
A herpes simplex type I subunit vaccine is prepared from infected chick embryo cells by ultra extraction of the virus while the infected cells are still attached to the growth surface.
REFERENCES:
patent: 4317811 (1982-03-01), Bertland et al.
Thomson et al., Infection & Immunity 41 (2): 556-562, Aug. 1983 Comparison of Effects of Adjuvants on Efficacy of Virion Envelope Herpes Simplex Virus Vaccine of Mice.
Allen et al., J. Inf. Dis. 145 (3): 413-420, Mar. 1982, Concept Review of Genital Herpes Vaccines.
Slichtova et al., Arch. Virol. 71:75-78 (1982) Immunogenicity of a Subviral Herpes Simplex Type I Preparation: Reduction of Recurrent Disease in Mice.
Hilfenhaus et al., Behring Inst. Mitt. No. 69: 45-56 (1981) Prospects for a Subunit Vaccine Against Herpes Simplex Virus Infections.
Schneweis et al., Med. Microbiol. Immunol. 169: 269-279 (1981) The Influence of Different Modes of Immunization on the Experimental Genital Herpes Simplex Virus Inf. of Mice.
Hilfenhaus et al., Med. Microbiol. Immunol. 169: 225-235 (1981) Protectivity of Herpes Simplex Virus Antigens: Studies in Mice on the Adjuvant Effect etc.
Klein et al., Arch. Virol. 68: 73-80 (1981) Efficacy of a Virion Envelope Herpes Simplex Virus Vaccine Against Experimental Skin Infections in Hairless Mice.
Cappel et al., Arch. Virol. 65: 15-23 (1980) Efficacy of a Nucleic Acid-Free Herpetic Subunit Vaccine.
Kitces et al., Infect. & Immun. 16: 955-960 Jun. 1977, Protection from Oral Herpes Simplex Virus Infection by Nucleic Acid-Free Virus Vaccine.
Glorioso et al. C.A. 86: 87551c (1977) of J. Immunol. 118(1): 114-121 (1977).
Cohen et al. CA. 89:103367s (1978) of J. Virol. (1978) 27 (1): 172-181.
Vestergaard C.A. 88: 134680x (1978) of P.S.E.B.M. 1977: 349-353.
Eisenberg C.A. 91: 173200x (1979) of J. Virol. (1979) 31 (3): 608-620.
Vestergaard C.A. 90:184708z (1979) of Infect. Immun. (1979) 23(3):553-558.
Chen C.A. 90: 134184e (1979) Virology (1978) 91 (2): 234-242.
Vestergaard C.A. 93: 225621y (1980) of Ger. Offen. 2949031 Jul. 17, 1980.
Hilfenhaus C.A. 96: 168577z (1982) of Behring Inst. Mitt. 1981 69: 45-56.
Thomson C.A. 99: 86277z (1983) of Infect. Immun. 1983 41 (2): 556-562.
Larson C.A. 98: 149580v (1983) of U.S. No. 4,374,127, Feb. 15, 1983.
Skinner C.A. 99: 200489x (1983) of Eur. Pat. Appl. Ep No. 89854, Sep. 28, 1983.
C.A. 70: 17866e (1969), Sitnikov et al.
C.A. 90: 97989y (1979), Tumilowicz et al.
C.A. 90: 109,946x (1979), Shiraishi et al.
C.A. 76: 139079v (1972), Burbidge.
Bertland Alexander U.
Lampson George P.
Elder Richard A.
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna J.
Rose Shep K.
LandOfFree
Herpes simplex type I subunit vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex type I subunit vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex type I subunit vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1428655